Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$2.85M
10K shares
What this filing means
DWEK RAYMOND plans to sell 10K shares of UNITED THERAPEUTICS CORP valued at approximately $2.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/21/2025ACC: 0001950047-25-002511
10K
Shares to sell
$2.85M
Approx. market value
3K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/21/2025
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/21/2025 | Stock Option Exercise Cash | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3K
Market value
$855.5K
4/14/2025
—Completed
Units to sell
4K
Market value
$1.14M
4/7/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$856.7K
4/21/2025
Total
Units
10K
Value
$2.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2025 | 3K | $855.5K | — | Completed |
4/7/2025 | 4K | $1.14M | — | Completed |
| Planned — Approximate Date | ||||
4/21/2025 | 3K | $856.7K | NASDAQ | Planned |
| Total | 10K | $2.85M | ||